E. Gallardo

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Rigshospitalet(Current)

Hospital Moinhos de Vento

Tallaght University Hospital

European Institute of Oncology

Hospital Israelita Albert Einstein

E. Gallardo is an author at Rigshospitalet specializing in metastatic disease treatment, prostate cancer hormonal therapy, and metastatic castration-resistant prostate cancer.

Publications per year

2024–2025

Publications

LBA1 A randomized multicenter open label phase III trial comparing enzalutamide vs a combination of Radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): First results of EORTC-GUCG 1333/PEACE-3

Silke Gillessen, Ananya Choudhury, F. Saad et al. · Annals of Oncology · 2024 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial

Bertrand Tombal, Ananya Choudhury, Farid Saad et al. · Annals of Oncology · 2025 · 36 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–2 of 2